Medicine
triCitrasol 14 g/30 mL solution
triCitrasol 14 g/30 mL solution is a prescription medicine containing Trisodium for extracorporeal use, marketed by Citra Labs, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Protect from freezing and exposure to excessive heat should be minimized. It…
Key facts
- Active ingredient (INN)
- Trisodium
- Brand
- triCitrasol
- Strength
- 14 g/30 mL
- Dosage form
- Solution
- Route
- Extracorporeal
- Packs
- 10 vials, 25 vials
- Marketing authorisation holder
- Citra Labs
- Manufacturer
- Citra Labs
- Origin register
- US FDA, United States
- Storage
- Protect from freezing and exposure to excessive heat should be minimized. It is recommended that the product be stored at ambient room temperature, 24°C (75°F), however, the product can be stored between 15°C (59°F) and 30°C (86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 10 July 2003
- Identifiers
- DailyMed set ID 64e7652c-1437-43bd-8ea2-3cafab447b8cNDC 23731-6030Application BN010409
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 10 vial, single-use in 1 case / 30 mL in 1 vial, single-use | 23731-6030-1 | Citra Labs | 10 July 2003 |
| 25 vial, single-use in 1 case / 30 mL in 1 vial, single-use | 23731-6030-2 | Citra Labs | 10 July 2003 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Trisodium
Clinical summary
Trisodium is an anti-coagulant. It is available as injection and solution for intravenous and extracorporeal use. MedsAcross supplies Trisodium for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about TrisodiumFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Sodium Citrate w/v Anticoagulant prescribing information (Terumo BCT) · U.S. National Library of Medicine, DailyMed
Need triCitrasol 14 g/30 mL solution for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.